Audit push: NFRA releases second audit practice toolkit; focuses on revenue risk assessment

The National Financial Reporting Authority (NFRA) on Thursday said it has rolled out its second Audit Practice Toolkit to support small and medium audit practitioners across the country, as part of its broader effort to improve the quality of auditing practices, PTI reported.The toolkit, titled ‘Risk & Response Memorandum: ROMM (Risk of Material Misstatement) Assessment…

Read More

Pension reform: PFRDA allows banks to set up pension funds for NPS; aims to boost competition

The Pension Fund Regulatory and Development Authority (PFRDA) on Thursday permitted banks to independently set up pension funds to manage the government’s flagship National Pension System (NPS), a move aimed at enhancing competition and safeguarding subscriber interests, PTI reported.The PFRDA board “has approved, in principle, a framework to permit Scheduled Commercial Banks (SCBs) to independently…

Read More

Insurance costs under lens: RBI flags high-cost distribution driving premium growth, warns of medium-term pressure

The Reserve Bank of India has flagged emerging structural pressures in the insurance sector, warning that premium growth is increasingly being driven by high-cost, distribution-led strategies rather than improvements in operating efficiency, even as the sector remains stable in the near term, according to its latest Financial Stability Report.“While posing no near-term systemic risks, the…

Read More

Global investing outlook 2026: Why investors may look beyond the US; how AI, rate cuts and a softer dollar will shape returns

Global investment opportunities are set to widen meaningfully in 2026 as easing monetary policy, a weakening US dollar and profit growth outside the United States reshape capital flows, according to Franklin Templeton report.The asset manager report titled ‘Global Investment Outlook 2026 and Beyond’ said that lobal markets are entering a phase where returns are likely…

Read More

Aurobindo Pharma acquires branded non-oncology prescription business of Khandelwal Labs’ for Rs 325 crore

HYDERABAD: Pharma major Aurobindo Pharma is acquiring the non-oncology prescription business of Mumbai-based Khandelwal Laboratories Pvt Ltd on a going concern, slump sale basis for a cash consideration of Rs 325 crore in a move aimed at strengthening its presence in the domestic formulations market.The acquisition, done through its wholly owned subsidiary Auro Pharma Limited,…

Read More

Euro switch: Bulgaria joins the euro nearly two decades after EU entry; cheers mix with fears over prices

Bulgaria on Thursday adopted the euro as its official currency, becoming the 21st country to join the eurozone, a long-anticipated milestone that comes almost 20 years after the Balkan nation entered the European Union, but one that has exposed deep political and public divisions.At midnight, Bulgaria formally gave up the lev, which had been in…

Read More